ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
2026 ARDC Annual Survey is now open!

The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your interaction with the ARDC and use of our national research infrastructure and services. The survey will take approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure services including Reasearch Link Australia.

We will use the information you provide to improve the national research infrastructure and services we deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) program.

Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.

Complete the 5 min survey now by clicking on the link below.

Take Survey Now

Thank you.

  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Intestinal Motility Disorders
Scheme : NHMRC Strategic Awards
Status : Closed
Clear All
Filter by Field of Research
Paediatrics not elsewhere classified (2)
Public Health and Health Services (2)
Central Nervous System (1)
Health Economics (1)
Medical and Health Sciences (1)
Medical microbiology not elsewhere classified (1)
Oncology and carcinogenesis not elsewhere classified (1)
Ophthalmology and optometry not elsewhere classified (1)
Psychiatry (incl. Psychotherapy) (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (11)
Filter by Status
Closed (11)
Filter by Scheme
NHMRC Strategic Awards (11)
Filter by Country
Australia (2)
Filter by Australian State/Territory
QLD (1)
VIC (1)
  • Researchers (0)
  • Funded Activities (11)
  • Organisations (24)
  • Funded Activity

    Novel Probiotics And Naturally-sourced Extracts As Treatment Strategies For Chemotherapy-induced

    Funder
    National Health and Medical Research Council
    Funding Amount
    $322,183.00
    Summary
    Intestinal mucositis is a serious disorder associated with chemotherapy treatment in cancer patients. Recently, a new strain of probiotic bacteria has been described with the potential to decrease the severity of intestinal mucositis. However, it is not known whether the live probiotic is necessary for this effect. We will compare the live probiotic, dead probiotic and factors sourced from this probiotic for the potential to decrease the severity of intestinal mucositis. Similarly, there have be .... Intestinal mucositis is a serious disorder associated with chemotherapy treatment in cancer patients. Recently, a new strain of probiotic bacteria has been described with the potential to decrease the severity of intestinal mucositis. However, it is not known whether the live probiotic is necessary for this effect. We will compare the live probiotic, dead probiotic and factors sourced from this probiotic for the potential to decrease the severity of intestinal mucositis. Similarly, there have been anecdotal claims of medicinal application for so-called ‘bioactive’ extracts and formulations derived from a range of mammalian, marine and plant sources. Specifically, Lyprinol (an extract derived from the New Zealand Green-Lipped Mussel), Emu Oil (derived from Emu meat) and the herbal extract Iberogast, have been reported to possess antiinflammatory properties. Indeed, these agents are used widely for the adjunctive relief of symptoms associated with arthritis and joint pain. However, these agents have yet to be tested for their potential to treat or prevent intestinal mucositis. For the first time, utilizing proven, controlled animal model systems, the current submission will explore the therapeutic potential of these agents, alone and in combination with indicated probiotics, for their capacity to treat or prevent mucositis. Should efficacy be demonstrated, a potential mechanism of action will be sought by investigating effects on intestinal stem cells.
    Read more Read less
    More information
    Funded Activity

    Clinical And Physiological Evaluation Of Chinese Herbal Medicine For Constipation Predominant Irritable Bowel Syndrome

    Funder
    National Health and Medical Research Council
    Funding Amount
    $592,705.00
    Summary
    This innovative study examines the effectiveness, safety and mechanisms of action of a complex Chinese herbal medicine (CHM) for irritable bowel syndrome (IBS). IBS is the most common chronic medical disorder of the digestive tract with 10% prevalence in the Australian population. Characterised by abdominal pain and altered bowel habits, it significantly affects quality of life and has major socioeconomic implications. IBS is increasingly recognized as a complex multi-factorial condition with ps .... This innovative study examines the effectiveness, safety and mechanisms of action of a complex Chinese herbal medicine (CHM) for irritable bowel syndrome (IBS). IBS is the most common chronic medical disorder of the digestive tract with 10% prevalence in the Australian population. Characterised by abdominal pain and altered bowel habits, it significantly affects quality of life and has major socioeconomic implications. IBS is increasingly recognized as a complex multi-factorial condition with psychogenic, hormonal and immune components. It is poorly addressed by current pharmaceutical treatments. Medical treatment of IBS remains unsatisfactory, with incomplete benefits offered by a single drug approach. The multi-factorial nature of IBS renders it an ideal candidate for evaluation with a more complex mix of low dose agents offered by herbal medicine. Specifically, CHMs by their complex chemical nature have substantial potential in the treatment of IBS because of their range of physiological effects on both bowel function and the central nervous systems We will perform a clinical trial of 8 weeks to determine the effectiveness of a chemically standardised CHM preparation in 160 patients with constipation predominant IBS patients compared to an identical placebo (sham). This project builds on our previous studies that demonstrated an effectiveness of CHM for IBS superior to current interventions. We’ve validated methods to ensure chemical standardisation of herbal medicines; validated approaches to psychosocial assessment of cognitive and behavioural changes in IBS patients; and have validated physiological, mechanistic evaluation of the lower bowel in response to treatment. The significance of the current proposal lies in its ability to provide a standardised, multi-component CHM (8 herbs) for the comprehensive clinical evaluation of the efficacy and safety of this type of therapy for IBS, and to provide insight into the relevant mechanisms of action. This project draws together the unique skills and previous studies from the Centre for Complementary Medicine Research (UWS), and the Gastrointestinal Investigation Unit of RNSH, USYD. This innovative project is medically important because it addresses a common gastrointestinal disorder with high socioeconomic implications for which conventional western medicine has failed to produce a cure or adequate palliative treatment.
    Read more Read less
    More information
    Funded Activity

    The Role Of Metabolic And Inflammatory Factors In Cognitive Decline And Cerebrovascular Pathology In The Elderly

    Funder
    National Health and Medical Research Council
    Funding Amount
    $945,987.00
    Summary
    Metabolic factors and measures of inflammation in the body have recently been shown to influence mental function and increase the risk of developing age-related disorders such as Alzheimer’s disease. The influence metabolic factors and inflammation have on function of the ageing brain is likely to be determined by complex interplay between many factors, such as physical health, lifestyle, nutrition and our genes. By studying these factors and how they relate to one another in large groups of eld .... Metabolic factors and measures of inflammation in the body have recently been shown to influence mental function and increase the risk of developing age-related disorders such as Alzheimer’s disease. The influence metabolic factors and inflammation have on function of the ageing brain is likely to be determined by complex interplay between many factors, such as physical health, lifestyle, nutrition and our genes. By studying these factors and how they relate to one another in large groups of elderly individuals, we will be able to determine the role these factors play in brain ageing. In addition we will be able to determine an ‘at risk’ profile for elderly individuals for accelerated ageing effects. Identification of this profile is important as it will allow the development of interventions which may prevent or delay the onset of cognitive decline in late life. We plan to study the impact of metabolic and inflammatory factors on brain ageing and in two groups of elderly individuals both of which are currently being studied in detail by our research team. By using these existing groups we will minimize the costs associated with our research, but maximize the research benefit and the benefit to society. Our groups include a large community sample of elderly individuals aged 70-90 years and a large group of elderly twins aged over 65 years. Our use of twins for the study is particularly important as it will help us separate genetic and environmental influences on the measures. We will measure multiple metabolic and inflammatory factors in the body and determine their relationship to detailed tests of cognitive function and to cerebrovascular pathology on brain magnetic resonance imaging. We will look at how these factors relate to one another and which factors are most strongly associated with accelerated ageing. We will be able to follow subjects in each group over a 2 year interval to see which factors most strongly predict change in cognitive function and cerebrovascular pathology over time. Our research is unique in its inclusion of multiple factors which may affect brain ageing, its ability to look in detail at the contribution of genetic influences on metabolic and inflammatory factors, and in our planned follow-up of these individuals.
    Read more Read less
    More information
    Funded Activity

    Assessment To Service Outcomes - Care Pathways For Older Australians With Dementia, CVD And Arthritis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $656,029.00
    Summary
    The project aims to use existing data source to answer questions similar to �What happens to people after they have been assessed and recommended for aged care? in respect of service delivery for people with one of the three chronic conditions dementia, arthritis or cardiovascular disease. The project is to provide information about issues such as �bed blockers� and determine if the outcomes are different for people who have been assessed for aged care while they are in hospital. It is to chart .... The project aims to use existing data source to answer questions similar to �What happens to people after they have been assessed and recommended for aged care? in respect of service delivery for people with one of the three chronic conditions dementia, arthritis or cardiovascular disease. The project is to provide information about issues such as �bed blockers� and determine if the outcomes are different for people who have been assessed for aged care while they are in hospital. It is to chart changes in service use over time and examine factors that affect the type of care used by older people.
    Read more Read less
    More information
    Funded Activity

    Understanding Factors Contributing To Nausea: Clinical And Patient Perspectives

    Funder
    National Health and Medical Research Council
    Funding Amount
    $100,000.00
    Summary
    This study aims to develop and validate indicators that can be used to more effectively identify nausea and its contributing factors in patients with advanced cancer receiving palliative care. Stage one involves a systematic review of the literature and qualitative interviews with patients and clinicians to identify clinical and psychosocial factors associated with nausea in the end stages of life. Stage 2 involves a study to evaluate the validity of the identified indicators in predicting patie .... This study aims to develop and validate indicators that can be used to more effectively identify nausea and its contributing factors in patients with advanced cancer receiving palliative care. Stage one involves a systematic review of the literature and qualitative interviews with patients and clinicians to identify clinical and psychosocial factors associated with nausea in the end stages of life. Stage 2 involves a study to evaluate the validity of the identified indicators in predicting patients’ experiences of nausea.
    Read more Read less
    More information
    Funded Activity

    Optimising Current Therapeutic Approaches To Schizophrenia: The OPTiMiSE Consortium

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,016,659.00
    Summary
    Despite modern treatments advances (medications and psychological treatments), the prognosis of schizophrenia has only improved marginally and is individually variable. The OPTiMiSE Consortium, consisting of leading experts in schizophrenia research across Europe and a group in Australia, will commence a 5-year research program world-first in scale and scope. We will investigate the biological markers related to treatment response in over 1000 individuals with recent-onset schizophrenia. Schizop .... Despite modern treatments advances (medications and psychological treatments), the prognosis of schizophrenia has only improved marginally and is individually variable. The OPTiMiSE Consortium, consisting of leading experts in schizophrenia research across Europe and a group in Australia, will commence a 5-year research program world-first in scale and scope. We will investigate the biological markers related to treatment response in over 1000 individuals with recent-onset schizophrenia. Schizophrenia is a chronic disease and despite modern medication and psychological treatments the outcome is highly variable and often poor. The Melbourne Neuropsychiatry Centre is part of the European based OPTiMiSE Consortium, the largest ever research program evaluating why individuals with schizophrenia vary in response to different medications. We will examine what characteristics predict which drugs are most helpful to 120 individuals with first episode schizophrenia
    Read more Read less
    More information
    Funded Activity

    Intergeneration Growth And Risk Of Metaboloc Disorders

    Funder
    National Health and Medical Research Council
    Funding Amount
    $2,095,469.00
    Summary
    A compelling raft of studies has now shown that low birth weight predisposes to later, impaired glucose tolerance, diabetes, cardiovascular disease, hypertension and high cholesterol. The associations are clearly evident even after adjusting for important lifestyle factors, occupation, income, adult diet and socio-economic status. This has resulted in a new paradigm for understanding the transmission of disease risk from one generation to the next. A team of researchers based at the University o .... A compelling raft of studies has now shown that low birth weight predisposes to later, impaired glucose tolerance, diabetes, cardiovascular disease, hypertension and high cholesterol. The associations are clearly evident even after adjusting for important lifestyle factors, occupation, income, adult diet and socio-economic status. This has resulted in a new paradigm for understanding the transmission of disease risk from one generation to the next. A team of researchers based at the University of Adelaide led by Dr Davies has gained international recognition for being at the forefront of this research. Thirty years ago, the group established the Lucina cohort to study intergenerational health among women, and how conditions in pregnancy can affect the reproductive health of offspring in successive generations. Dr Davies and his team of researchers will expand this study in ways that were designed at the outset, but not commenced until now. This includes enrolling the traced mothers to study how their clinical experiences in pregnancy predict their own later risk of diabetes. We will also be seeking to enrol the siblings of the daughters so that we can identify events in pregnancies that predict which sibling is at increased risk of diabetes. Finally, the study will enrol the grandchildren and trace their birth records so that we can study the relationship between diabetes risk, intergenerational growth and how that risk can be substantially influenced by factors as basic as pre-pregnancy body weight and weight gain in pregnancy. The objective of this research is to grow healthier Australian babies, children and thereby healthier adults.
    Read more Read less
    More information
    Funded Activity

    Outcome And Process Evaluation Of An Ergonomics Program Intervention To Prevent Occupational Musculoskeletal Injuries

    Funder
    National Health and Medical Research Council
    Funding Amount
    $106,377.00
    More information
    Funded Activity

    Neuroscience On Barriers In Development (NEUROBID)

    Funder
    National Health and Medical Research Council
    Funding Amount
    $600,927.00
    Summary
    The program aims to understand normal and disturbed brain barrier function in development to devise ways of preventing or ameliorating neurological conditions in infants or adult neurological disorders with developmental origins. Unique features of transport mechanisms across brain barriers will be used to design novel methods of targeting therapeutic macromolecular and cellular agents to the brain barriers and transporting them into brain for treatment of neurological diseases in young and old.
    More information
    Funded Activity

    Enhancing Mental Health In Aboriginal People: Reducing Violence And Developing Resilience

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,771,151.00
    Summary
    This project aims to determine the best ways to improve the Social Emotional Well Being (SEWB) of the Aboriginal people of Broken Hill, Menindee and Wilcannia. This project will develop a culturally appropriate and evidenced based intervention to break the cycle of ongoing grief, mental illness, alcohol and other drugs and violence. The project will proceed in a number of interrelated phases including extensive community consultations and a baseline survey. The project will then implement and ev .... This project aims to determine the best ways to improve the Social Emotional Well Being (SEWB) of the Aboriginal people of Broken Hill, Menindee and Wilcannia. This project will develop a culturally appropriate and evidenced based intervention to break the cycle of ongoing grief, mental illness, alcohol and other drugs and violence. The project will proceed in a number of interrelated phases including extensive community consultations and a baseline survey. The project will then implement and evaluate an intervention program that provides a community and individual program that adopts evidence-based approaches and modifies them to be acceptable within Aboriginal communities. These interventions aim to break the cycle of violence and mental health problems by teaching adaptive skills to reduce violent behaviours and by providing mental health interventions that reduce disorders that contribute to violence.
    Read more Read less
    More information

    Showing 1-10 of 11 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback